Showing codes J2797 (Injection, rolapitant, 0.5 mg) — J3055 (Injection, talquetamab-tgvs, 0.25 mg)

J2797 - Inj., rolapitant, 0.5 mg
Long description: Injection, rolapitant, 0.5 mg
Code added date: 20190101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2798 - Inj., perseris, 0.5 mg
Long description: Injection, risperidone, (perseris), 0.5 mg
Code added date: 20191001.
Code effective date: 20220101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J2799 - Inj, uzedy, 1 mg
Long description: Injection, risperidone (uzedy), 1 mg
Code added date: 20240101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J2800 - Methocarbamol injection
Long description: Injection, methocarbamol, up to 10 ml
Code added date: 19820101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2801 - Inj, rykindo, 0.5 mg
Long description: Injection, risperidone (rykindo), 0.5 mg
Code added date: 20240401.
Code effective date: 20240401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J2805 - Sincalide injection
Long description: Injection, sincalide, 5 micrograms
Code added date: 20060101.
Code effective date: 20060101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J2806 - Inj sincalide, maia, 5 mcg
Long description: Injection, sincalide (maia) not therapeutically equivalent to j2805, 5 micrograms
Code added date: 20230701.
Code effective date: 20230701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J2810 - Inj theophylline per 40 mg
Long description: Injection, theophylline, per 40 mg
Code added date: 19820101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2820 - Sargramostim injection
Long description: Injection, sargramostim (gm-csf), 50 mcg
Code added date: 19820101.
Code effective date: 19980101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2840 - Inj sebelipase alfa 1 mg
Long description: Injection, sebelipase alfa, 1 mg
Code added date: 20170101.
Code effective date: 20170101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J2850 - Inj secretin synthetic human
Long description: Injection, secretin, synthetic, human, 1 microgram
Code added date: 20060101.
Code effective date: 20060101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2860 - Injection, siltuximab
Long description: Injection, siltuximab, 10 mg
Code added date: 20160101.
Code effective date: 20160101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J2910 - Aurothioglucose injeciton
Long description: Injection, aurothioglucose, up to 50 mg
Code added date: 19820101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2916 - Na ferric gluconate complex
Long description: Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg
Code added date: 20030101.
Code effective date: 20030101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2919 - Inj, methylpred sod succ 5mg
Long description: Injection, methylprednisolone sodium succinate, 5 mg
Code added date: 20240401.
Code effective date: 20240401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2920 - Methylprednisolone injection
Long description: Injection, methylprednisolone sodium succinate, up to 40 mg
Code added date: 19820101.
Code effective date: 20240401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2930 - Methylprednisolone injection
Long description: Injection, methylprednisolone sodium succinate, up to 125 mg
Code added date: 19840101.
Code effective date: 20240401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2940 - Somatrem injection
Long description: Injection, somatrem, 1 mg
Code added date: 20020101.
Code effective date: 20020101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2941 - Somatropin injection
Long description: Injection, somatropin, 1 mg
Code added date: 20020101.
Code effective date: 20230101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2950 - Promazine hcl injection
Long description: Injection, promazine hcl, up to 25 mg
Code added date: 19820101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2993 - Reteplase injection
Long description: Injection, reteplase, 18.1 mg
Code added date: 20010101.
Code effective date: 20010101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2995 - Inj streptokinase /250000 iu
Long description: Injection, streptokinase, per 250,000 iu
Code added date: 19860101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2997 - Alteplase recombinant
Long description: Injection, alteplase recombinant, 1 mg
Code added date: 20010101.
Code effective date: 20010101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J2998 - Inj plasminogen tvmh 1mg
Long description: Injection, plasminogen, human-tvmh, 1 mg
Code added date: 20220701.
Code effective date: 20220701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J3 - Cap drug unavail thru cap
Long description: Competitive acquisition program (cap), drug not available through cap as written, reimbursed under average sales price methodology
Code added date: 20060101.
Code effective date: 20060101.
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J3000 - Streptomycin injection
Long description: Injection, streptomycin, up to 1 gm
Code added date: 19820101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J3010 - Fentanyl citrate injection
Long description: Injection, fentanyl citrate, 0.1 mg
Code added date: 19820101.
Code effective date: 20010101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J3030 - Sumatriptan succinate / 6 mg
Long description: Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
Code added date: 19860101.
Code effective date: 20000101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J3031 - Inj., fremanezumab-vfrm 1 mg
Long description: Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)
Code added date: 20191001.
Code effective date: 20191001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J3032 - Inj. eptinezumab-jjmr 1 mg
Long description: Injection, eptinezumab-jjmr, 1 mg
Code added date: 20201001.
Code effective date: 20201001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J3055 - Inj talquetamab-tgvs 0.25 mg
Long description: Injection, talquetamab-tgvs, 0.25 mg
Code added date: 20240401.
Code effective date: 20240401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF